Skip to content
Lotus Eye Hospital logo

Lotus Eye Hospital

LOTUSEYE NSE
₹109.54 0.11 (0.10%)
Market Cap
₹228 Cr
P/E
1564.86

Lotus Eye Hospital (LOTUSEYE) share price was ₹109.54 at the 28 Oct 2026 close; market capitalisation ₹228 Cr; P/E (TTM) 1564.86; sector Healthcare Services. The share price fell 8.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 26.2% year on year to ₹17.06 Cr and net profit was ₹0.61 Cr, against ₹0.54 Cr a year earlier (compared with Jun 2025). Promoters held 40.14% of Lotus Eye Hospital in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 37/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹109.54 −10.55 −8.79% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹228 Cr
P/E (TTM)
1,564.86
EBITDA
₹4.60 Cr
Return on Equity
0.13%
Debt to Equity
0.26
Book Value
₹28.92
EPS (TTM)
₹0.07
52W High
₹147.00
52W Low
₹97.59

Price-based figures as of 28 Oct 2026, 15:52 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Apollo Hospitals
₹8,137.0055.991,16,998 Cr12.340.26%20.08%19.79%26,675 Cr2,171 Cr
Manipal Health Enterprises
₹643.2585.7784,612 Cr5.150.00%10.42%9.50%11,400 Cr906 Cr
Max Healthcare Institute
₹851.5056.8482,877 Cr7.710.24%13.42%12.70%8,879 Cr1,457 Cr
Aster DM Healthcare
₹669.45108.8558,354 Cr13.870.45%8.84%9.71%5,006 Cr363 Cr
Fortis Healthcare
₹759.5054.7257,339 Cr5.790.14%10.47%12.13%9,607 Cr1,070 Cr
Narayana Hrudayalaya
₹1,723.1043.1435,213 Cr7.760.26%17.85%11.39%9,185 Cr816 Cr
Global Health
₹1,283.0062.0134,496 Cr8.710.04%13.91%15.05%4,800 Cr552 Cr
Lotus Eye Hospital (this company)
₹109.541,564.86228 Cr3.790.46%0.13%1.10%59 Cr0 Cr
Median 8 companies₹805.5059.4357,847 Cr7.730.25%11.95%11.76%9,032 Cr861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
37 Weak
Overall score
Data confidence 100/100
pledge:87%

Category scores

Quality Average 46
Returns, margins, earnings quality 22%
Valuation Poor 21
Cheap vs sector & own history 24%
Growth Good 57
Sales & profit trajectory 9%
Financial Health Average 51
Solvency, leverage, coverage 9%
Momentum Weak 44
Trend strength, vol-adjusted 12%
Ownership Average 50
FII/DII/promoter flows 24%
Capped: a governance trigger overrides the fundamentals here (pledge>75% ≤ 40).

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

7
  • Stock is trading at 3.70 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 10.7% over past five years.
  • Company has a low return on equity of 2.09% over last 3 years.
  • Promoters have pledged 87.2% of their holding.
  • Promoter holding has decreased over last 3 years: -17.4%

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
7
Bullish
0

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
7.86% higher than 3Y

change over 1 year

Net Income Growth
-85.71% lower than 3Y

change over 1 year

Cash Flow Change
11.85%

change over 1 year

EBITDA Margin Change
-10.74%

change over 1 year Operating margin 17.29% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
12.57
12.73
12.03
10.88
12.89
12.91
12.25
11.51
13.52
13.04
13.55
13.61
17.06
Expenses
10.18
10.92
10.45
10.12
11.23
11.76
11.46
11.68
12.04
12.27
12.89
13.13
14.11
Operating Profit
2.39
1.81
1.58
0.76
1.66
1.15
0.79
-0.17
1.48
0.77
0.66
0.48
2.95
OPM %
19.01%
14.22%
13.13%
6.99%
12.88%
8.91%
6.45%
-1.48%
10.95%
5.9%
4.87%
3.53%
17.29%
Other Income
0.29
0.28
0.34
0.4
0.31
0.27
0.22
0.52
0.19
0.27
0.24
0.47
0.21
Interest
0.02
0.01
0.04
0.03
0.06
0.08
0.13
0.09
0.12
0.12
0.29
0.33
0.51
Depreciation
0.73
0.89
0.98
1.12
1.06
1.23
1.31
-0.58
0.82
0.85
0.98
1.1
1.64
PBT
1.93
1.19
0.9
0.01
0.85
0.11
-0.43
0.84
0.73
0.07
-0.37
-0.48
1.01
Tax %
27.98%
28.57%
26.67%
-200%
28.24%
9.09%
-44.19%
70.24%
24.66%
-71.43%
-29.73%
-33.33%
39.6%
Net Profit
1.38
0.85
0.66
0.02
0.62
0.1
-0.24
0.25
0.54
0.12
-0.26
-0.32
0.61
EPS (₹)
0.66
0.41
0.32
0.01
0.3
0.05
-0.12
0.12
0.26
0.06
-0.13
-0.15
0.29
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
29.9
31.13
33.96
38.02
38.43
40.55
32.35
38.9
47.03
48.2
49.55
53.7
57.26
Expenses
27.72
27.14
30.63
33.68
35.21
36.57
28.73
32.98
39.35
41.57
45.99
50.15
52.4
Operating Profit
2.18
3.99
3.33
4.34
3.22
3.98
3.62
5.92
7.68
6.63
3.56
3.55
4.86
OPM %
7.29%
12.82%
9.81%
11.42%
8.38%
9.82%
11.19%
15.22%
16.33%
13.76%
7.18%
6.61%
8.49%
Other Income
0.46
0.58
0.68
0.91
0.68
0.21
0.84
0.88
1.15
1.31
1.31
1.18
1.19
Interest
0.1
0.16
0.15
0.18
0.21
0.24
0.14
0.21
0.2
0.2
0.48
1.03
1.25
Depreciation
4.76
4.44
3.44
3.37
3.06
2.5
2.33
2.5
2.98
3.73
3.01
3.75
4.57
PBT
-2.22
-0.03
0.42
1.7
0.63
1.45
1.99
4.09
5.65
4.01
1.38
-0.05
0.23
Tax %
-10.81%
-400%
-7.14%
-2.35%
-12.7%
26.9%
21.11%
27.14%
27.79%
27.43%
46.38%
-280%
—
Net Profit
-1.98
0.1
0.44
1.75
0.71
1.06
1.57
2.98
4.08
2.91
0.74
0.08
0.15
EPS (₹)
-0.95
0.05
0.21
0.84
0.34
0.51
0.75
1.43
1.96
1.4
0.36
0.04
0.07
Div. Payout %
0%
0%
236.36%
59.43%
0%
0%
66.24%
34.9%
25.49%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
20.8
20.8
20.8
20.8
20.8
20.8
20.8
20.8
20.8
20.8
20.8
20.8
Reserves
28.59
28.69
29.26
29.84
29.32
30.46
31.9
33.81
36.78
38.61
39.2
39.34
Borrowings
0.83
0.66
0.48
0.29
0.22
0.32
0.4
1.24
0.67
1.11
3.43
15.83
Other Liabilities
6.2
4.68
4.4
7.28
6.18
6.53
6.12
5.75
4.93
6.11
6.14
6.63
Total Liabilities
56.42
54.83
54.94
58.21
56.52
58.11
59.22
61.6
63.18
66.63
69.57
82.6
Fixed Assets
47.04
43.57
41.32
42.52
44.14
42.67
40.54
44.07
44.18
48.65
54.07
65.81
CWIP
0.27
0.42
0.65
0.29
0.29
0
0
0
0
0.08
0
0.09
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
9.11
10.84
12.97
15.4
12.09
15.44
18.68
17.53
19
17.9
15.5
16.7
Total Assets
56.42
54.83
54.94
58.21
56.52
58.11
59.22
61.6
63.18
66.63
69.57
82.6
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2.37
3.38
2.97
5.78
4.2
4.97
2.73
4.41
4.39
5.68
2.7
3.02
Investing
-4.65
-0.85
-1.06
-3.86
-4.01
-0.68
0.49
-3.94
-2.19
-4.63
-6.13
-14.39
Financing
1.87
-0.58
-0.25
-1.51
-1.41
0.13
-0.32
-1.58
-1.71
-3.4
-1.6
9.03
Net Cash Flow
-0.4
1.96
1.66
0.41
-1.22
4.42
2.9
-1.1
0.49
-2.35
-5.03
-2.34
Free Cash Flow
-2.38
2.28
1.55
1.58
-0.49
3.54
2.61
-0.25
1.3
0.1
-2.09
-10.01
CFO/OP
109
85
92
142
134
132
84
89
76
101
94
94
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
4.27
5.98
7.31
10.94
7.22
5.94
8.35
5.82
9.08
9.54
9.72
8.22
Inventory Days
122
113
60.22
79.23
128
124
139
150
154
170
194
172
Days Payable
125
106
87.32
130
167
170
221
231
173
184
170
146
Cash Conversion Cycle
0.73
13.72
-19.79
-39.78
-31.95
-40.05
-73.54
-75.37
-10.74
-3.72
33.48
34.3
Working Capital Days
-19.9
-8.56
-8.92
-26.02
-15.39
-21.33
-23.92
-16.33
8.61
5.68
0
-12.17
ROCE %
-4.23%
0.24%
1.19%
3.63%
1.66%
4.67%
3.92%
7.91%
10.25%
7.07%
2.99%
1.41%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Lotus Eye Hospital insights

61 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

DIIs0.02%Promot.40.14%Others23.98%Public35.87%As ofSep 2026
87.15% of promoter holding pledged as of Sep 2026

Documents

Frequently Asked Questions about Lotus Eye Hospital

What does Lotus Eye Hospital & Institute Ltd do?
Incorporated in 1990, Lotus Eye Hospital and Institute Ltd provides ophthalmology and other related services.[1]
Where is Lotus Eye Hospital & Institute Ltd (LOTUSEYE) listed?
Lotus Eye Hospital & Institute Ltd trades as LOTUSEYE on the NSE and under code 532998 on the BSE.
Which sector does Lotus Eye Hospital & Institute Ltd belong to?
Lotus Eye Hospital & Institute Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Lotus Eye Hospital & Institute Ltd?
Lotus Eye Hospital & Institute Ltd has a market capitalisation of ₹227.8 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Lotus Eye Hospital & Institute Ltd?
Lotus Eye Hospital & Institute Ltd trades at a PE ratio of 1564.86 as of 28 Oct 2026, on earnings per share of ₹0.07, against a book value of ₹28.92 per share.
What is the 52-week high and low of Lotus Eye Hospital & Institute Ltd?
Over the last 52 weeks Lotus Eye Hospital & Institute Ltd has traded between ₹97.59 and ₹147 as of 28 Oct 2026.
Does Lotus Eye Hospital & Institute Ltd pay dividends?
Lotus Eye Hospital & Institute Ltd has a dividend yield of 0.46%.
What is the Return on Equity (ROE) of Lotus Eye Hospital & Institute Ltd?
Lotus Eye Hospital & Institute Ltd reported a return on equity of 0.13%. Its debt-to-equity ratio is 0.26.

Company Information

Incorporated in 1990, Lotus Eye Hospital and Institute Ltd provides ophthalmology and other related services.[1]

Website lotuseye.org
CEO Ms. Sangeetha Sundaramoorthy
Employees 348
Listed 2008-07-11
Face Value ₹ 10
Shares Outstanding 2,07,96,330

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/LOTUSEYE.md for Lotus Eye Hospital & Institute Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month